InsiderDB
Sign inStart free trial

Rep. Greg Stanton sold Gilead Sciences (GILD)

Rep. Greg Stanton (D-AZ-4) · $1K–$15K · traded Oct 24, 2023

Transaction
Sold
Amount
$1K–$15K
Owner
Spouse
Traded
Oct 24, 2023
Disclosed
Nov 9, 2023
Days to disclose
16
Asset type
Stock
As filed
Gilead Sciences, Inc.
Industry
Drug Manufacturers - General · Healthcare
Official filing ↗All of Stanton's tradesAll Congress trades in GILD

Other trades in this filing

All of Stanton's trades →

  • Sold Starbucks SBUX

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

  • Sold Amazon.com AMZN

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

  • Sold Stryker SYK

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

  • Sold Palo Alto Networks PANW

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

  • Sold Merck & Co. MRK

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

  • Sold Walmart WMT

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

    Got $2K from the company’s PAC

  • Sold Comcast CMCSA

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

    Got $7K from the company’s PAC

  • Sold McDonald's MCD

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

  • Sold Berkshire Hathaway BRK-B

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

  • Sold Jacobs Solutions J

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

  • Sold Alphabet GOOG

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

  • Sold Bristol-Myers Squibb Company BMY

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

  • Sold The Walt Disney Company DIS

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

  • Sold Verizon Communications VZ

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

    Got $5K from the company’s PAC

  • Sold United Parcel Service UPS

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

    Got $8K from the company’s PAC

  • Sold JPMorgan Chase & JPM

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

    Got $2K from the company’s PAC

  • Sold Deere & Company DE

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

  • Sold The Progressive PGR

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

  • Sold Linde LIN

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

  • Sold AbbVie ABBV

    $1K–$15K · Traded Oct 24, 2023 · disclosed Nov 9, 2023 · Spouse

Recent Congress trades in GILD

Company context for GILD

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. GILDFinancial report·SEC EDGAR

    GILD: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Oct 29, 2026, 8:09 PM EDTEvent / period: Sep 30, 2026Original source ↗
  2. GILDCompany announcement·SEC EDGAR

    GILD: Financial results

    Filed 8-K for an event or period dated 2026-10-29. Financial results.

    Public: Oct 29, 2026, 4:03 PM EDTEvent / period: Oct 29, 2026Original source ↗
  3. GILDLobbying report·Lobbying disclosures

    GILD: third_quarter 2026 lobbying report

    Advocate on domestic and global drug pricing proposals, international trade and protection of intellectual property; global supply chain issues, including the Medical Supply Chain Resiliency Act and tariffs; compulsory licensing and other IP issues in multiple countries. Funding for policies relating to domestic and international HIV, Hepatitis C, oncology, and public health activities via appropriations. Advocacy regarding drug pricing proposals, including provisions modifying the Inflation Reduction Act and government purchasing proposals. Advocate on drug pricing proposals. Proposals to exp

    Public: Oct 21, 2026, 1:36 PM EDTOriginal source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.